GALT - Galectin Therapeutics Inc.

Name: Galectin Therapeutics Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Richard E Uihlein	44.71M	$149.79M	-
10%	10x Fund, L.P.	5.61M	$18.81M	-
CEO	Joel Lewis	832.6K	$2.79M	-
Dir	Kary Eldred	65.7K	$220.0K	-
Dir	Kevin D Freeman	55.3K	$185.2K	-

Activity

Buys and sells only

Transactions

10 filings · page 11

Date	Insider	Role	Type	Shares	Price	Value	Chg%
May 31, 2019	Kary Eldred81	Director	Buy	3,033	$4.28	$12,981.24	+7.3%
May 31, 2019	Kevin D Freeman57	Director	Buy	9,136	$4.28	$39,102.08	+63.7%
May 31, 2019	Gilbert S Omenn	Director	Buy	18,578	$4.28	$79,513.84	+38.6%
May 31, 2019	Joel Lewis	Director	Buy	12,849	$4.28	$54,993.72	+19.5%
May 31, 2019	Richard E Uihlein	Director, 10% Owner	Buy	4,680,606	$4.28	$20,032,993.68	-100.6%
Apr 9, 2019	Richard E Uihlein	Director, 10% Owner	Buy	20,700	$4.82	$99,850.59	+0.8%
Apr 5, 2019	Kevin D Freeman57	Director	Buy	500	$4.73	$2,365.00	+33.3%
Apr 5, 2019	Richard E Uihlein	Director, 10% Owner	Buy	21,000	$4.81	$100,972.20	+0.8%
Apr 5, 2019	Joel Lewis67	Director	Buy	667	$4.82	$3,214.07	+1.0%
Feb 22, 2019	Marc Rubin	Director	Sale+OE	51,185	$6.02	$308,201.11	-79.0%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC